Milton H. Grannatt
Director/Board Member at Myopharm Ltd.
Profile
Milton H.
Grannatt is currently a Non-Executive Director at Myopharm Ltd.
He was previously an Outside Director at SymBio Pharmaceuticals Ltd.
Grannatt earned a doctorate degree from Lehigh University in 1975.
Milton H. Grannatt active positions
| Companies | Position | Start |
|---|---|---|
Myopharm Ltd.
 Myopharm Ltd. BiotechnologyHealth Technology Myopharm Ltd. develops and produces nutrition specifically for individuals with type 2 diabetes. The Australian company was founded in 2020 and the CEO is Karinza Phoenix. | Director/Board Member | - |
Former positions of Milton H. Grannatt
| Companies | Position | End |
|---|---|---|
| SYMBIO PHARMACEUTICALS LIMITED | Director/Board Member | - |
Training of Milton H. Grannatt
| Lehigh University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SYMBIO PHARMACEUTICALS LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
Myopharm Ltd.
Myopharm Ltd. BiotechnologyHealth Technology Myopharm Ltd. develops and produces nutrition specifically for individuals with type 2 diabetes. The Australian company was founded in 2020 and the CEO is Karinza Phoenix. | Health Technology |
- Stock Market
- Insiders
- Milton H. Grannatt
